Title : Novel therapies targeting the myeloma cell and its bone marrow microenvironment.

Pub. Date : 2001 Dec

PMID : 11740818






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PS-341 inhibits p44/42 mitogen-activated protein kinase (MAPK) growth signaling triggered by IL-6 and induces apoptosis, despite induction of p21 and p27, in p53 wild-type and p53 mutant MM cells. Bortezomib interleukin 6 Homo sapiens
2 PS-341 adds to the anti-MM activity of dexamethasone and overcomes IL-6-mediated protection against dexamethasone-induced apoptosis. Bortezomib interleukin 6 Homo sapiens
3 PS-341 blocks the paracrine growth of human MM cells by decreasing their adherence to BMSCs and related NF-kappaB-dependent induction of IL-6 secretion in BMSCs. Bortezomib interleukin 6 Homo sapiens